Flavin Financial Services Inc. Invests $964,000 in Kenvue Inc. (NYSE:KVUE)

Flavin Financial Services Inc. acquired a new stake in Kenvue Inc. (NYSE:KVUE) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 45,145 shares of the company’s stock, valued at approximately $964,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Columbus Macro LLC raised its stake in Kenvue by 203.1% during the 4th quarter. Columbus Macro LLC now owns 223,588 shares of the company’s stock valued at $4,774,000 after buying an additional 149,819 shares during the last quarter. Childress Capital Advisors LLC increased its stake in shares of Kenvue by 11.4% in the 4th quarter. Childress Capital Advisors LLC now owns 16,090 shares of the company’s stock worth $344,000 after purchasing an additional 1,642 shares in the last quarter. Renaissance Capital LLC increased its stake in Kenvue by 9.3% in the 4th quarter. Renaissance Capital LLC now owns 723,592 shares of the company’s stock worth $15,449,000 after buying an additional 61,330 shares in the last quarter. One Wealth Advisors LLC increased its stake in Kenvue by 31.4% in the 4th quarter. One Wealth Advisors LLC now owns 12,131 shares of the company’s stock worth $259,000 after buying an additional 2,897 shares in the last quarter. Finally, Willis Investment Counsel increased its stake in Kenvue by 0.6% in the 4th quarter. Willis Investment Counsel now owns 888,983 shares of the company’s stock worth $18,980,000 after buying an additional 5,231 shares in the last quarter. 97.64% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have commented on KVUE shares. Royal Bank of Canada reissued a “sector perform” rating and set a $24.00 price objective on shares of Kenvue in a report on Monday. Citigroup reduced their target price on shares of Kenvue from $25.00 to $21.00 and set a “neutral” rating on the stock in a research report on Wednesday, January 15th. JPMorgan Chase & Co. lifted their price objective on shares of Kenvue from $24.00 to $25.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Barclays cut their price objective on shares of Kenvue from $23.00 to $21.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. Finally, UBS Group lowered their target price on shares of Kenvue from $24.00 to $23.00 and set a “neutral” rating for the company in a research note on Thursday, January 16th. One analyst has rated the stock with a sell rating, eight have given a hold rating and four have issued a buy rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $23.08.

Kenvue Trading Down 0.3 %

NYSE KVUE opened at $21.22 on Tuesday. Kenvue Inc. has a 1 year low of $17.67 and a 1 year high of $24.46. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. The company has a fifty day moving average of $21.90 and a 200 day moving average of $21.92. The company has a market capitalization of $40.69 billion, a PE ratio of 38.59, a P/E/G ratio of 2.05 and a beta of 1.45.

Kenvue (NYSE:KVUE) last released its earnings results on Thursday, November 7th. The company reported $0.28 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.01. The business had revenue of $3.90 billion during the quarter, compared to analysts’ expectations of $3.92 billion. Kenvue had a net margin of 6.88% and a return on equity of 21.43%. The company’s quarterly revenue was down .4% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.31 earnings per share. Research analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, February 26th. Stockholders of record on Wednesday, February 12th will be paid a dividend of $0.205 per share. The ex-dividend date of this dividend is Wednesday, February 12th. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.86%. Kenvue’s dividend payout ratio is currently 149.09%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.